{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T03:34:37Z","timestamp":1793504077038,"version":"4.5.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T00:00:00Z","timestamp":1694736000000},"content-version":"am","delay-in-days":379,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-AI-101175"],"award-info":[{"award-number":["R01-AI-101175"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-AI-144365"],"award-info":[{"award-number":["R01-AI-144365"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001229","name":"G. Harold and Leila Y. Mathers Charitable Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001229","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014731","name":"Global Lyme Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.idc.2022.03.006","type":"journal-article","created":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T18:42:06Z","timestamp":1663267326000},"page":"563-577","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["Lyme Arthritis"],"prefix":"10.1016","volume":"36","author":[{"given":"Sheila L.","family":"Arvikar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen C.","family":"Steere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.idc.2022.03.006_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/art.1780200102","article-title":"Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three Connecticut communities","volume":"20","author":"Steere","year":"1977","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.idc.2022.03.006_bib2","doi-asserted-by":"crossref","first-page":"685","DOI":"10.7326\/0003-4819-86-6-685","article-title":"Erythema chronicum migrans and Lyme arthritis. the enlarging clinical spectrum","volume":"86","author":"Steere","year":"1977","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.idc.2022.03.006_bib3","doi-asserted-by":"crossref","first-page":"725","DOI":"10.7326\/0003-4819-107-5-725","article-title":"The clinical evolution of Lyme arthritis","volume":"107","author":"Steere","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.idc.2022.03.006_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6622a1","article-title":"Surveillance for Lyme disease\u2014United States, 2008-2015","volume":"66","author":"Schwartz","year":"2017","journal-title":"MMWR Surveill Summ"},{"key":"10.1016\/j.idc.2022.03.006_bib5","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3201\/eid2702.202731","article-title":"Estimating the frequency of Lyme disease diagnoses \u2013 United States, 1020-2018","volume":"27","author":"Kugeler","year":"2021","journal-title":"Emerg Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2022.03.006_bib6","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1056\/NEJM198908313210906","article-title":"Lyme disease","volume":"321","author":"Steere","year":"1989","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.idc.2022.03.006_bib7","doi-asserted-by":"crossref","first-page":"16090","DOI":"10.1038\/nrdp.2016.90","article-title":"Lyme borreliosis","volume":"15","author":"Steere","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"9","key":"10.1016\/j.idc.2022.03.006_bib8","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1086\/592279","article-title":"Borrelia burgdorferi genotype predicts the capacity for hematogenous dissemination during early Lyme disease","volume":"198","author":"Wormser","year":"2008","journal-title":"J\u00a0Infect Dis"},{"issue":"7","key":"10.1016\/j.idc.2022.03.006_bib9","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1002\/art.24812","article-title":"Analysis of Borrelia burgdorferi genotypes in patients with Lyme arthritis: High frequency of ribosomal RNA intergenic spacer type 1 strains in antibiotic-refractory arthritis","volume":"60","author":"Jones","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.idc.2022.03.006_bib10","doi-asserted-by":"crossref","first-page":"e73066","DOI":"10.1371\/journal.pone.0073066","article-title":"Multilocus sequence typing of Borrelia burgdorferi suggests existence of lineages with differential pathogenic properties in humans","volume":"8","author":"Hanincova","year":"2013","journal-title":"PLoS One"},{"issue":"35","key":"10.1016\/j.idc.2022.03.006_bib11","doi-asserted-by":"crossref","first-page":"15013","DOI":"10.1073\/pnas.0903810106","article-title":"Phylogeography of Borrelia burgdorferi in the eastern United States reflects multiple independent Lyme disease emergence events","volume":"106","author":"Hoen","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"10.1016\/j.idc.2022.03.006_bib12","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s10067-012-1964-x","article-title":"The amber theory of Lyme arthritis: initial description and clinical implications","volume":"31","author":"Wormser","year":"2012","journal-title":"Clin Rheumatol"},{"issue":"8","key":"10.1016\/j.idc.2022.03.006_bib13","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1172\/JCI21681","article-title":"The emergence of Lyme disease","volume":"113","author":"Steere","year":"2004","journal-title":"J\u00a0Clin Invest"},{"issue":"10","key":"10.1016\/j.idc.2022.03.006_bib14","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1002\/art.22131","article-title":"Therapy for Lyme arthritis: strategies for the treatment of antibiotic-refractory arthritis","volume":"54","author":"Steere","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.idc.2022.03.006_bib15","first-page":"2025","article-title":"Lyme arthritis in children and adolescents: outcome 12\u00a0months after initiation of antibiotic therapy","volume":"27","author":"Bentas","year":"2000","journal-title":"J\u00a0Rheumatol"},{"issue":"8","key":"10.1016\/j.idc.2022.03.006_bib16","doi-asserted-by":"crossref","first-page":"943","DOI":"10.3899\/jrheum.180775","article-title":"Pediatric antibiotic-refractory Lyme arthritis: a multicenter case-control study","volume":"46","author":"Horton","year":"2019","journal-title":"J\u00a0Rheumatol"},{"issue":"2","key":"10.1016\/j.idc.2022.03.006_bib17","doi-asserted-by":"crossref","first-page":"e12954","DOI":"10.1111\/cmi.12954","article-title":"Robust interferon signature and suppressed tissue repair gene expression in synovial tissue from patients with postinfectious, Borrelia burgdorferi-induced Lyme arthritis","volume":"21","author":"Lochhead","year":"2019","journal-title":"Cell Microbiol"},{"issue":"8","key":"10.1016\/j.idc.2022.03.006_bib18","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41584-021-00648-5","article-title":"Lyme arthritis: linking infection, inflammation and autoimmunity","volume":"17","author":"Lochhead","year":"2021","journal-title":"Nat Rev Rheumatol"},{"issue":"8","key":"10.1016\/j.idc.2022.03.006_bib19","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1002\/art.30384","article-title":"Burden and viability of Borrelia burgdorferi in skin or joints of patients with erythema migrans or Lyme arthritis","volume":"63","author":"Li","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.idc.2022.03.006_bib20","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1172\/JCI58813","article-title":"Spirochete antigens persist near cartilage after murine Lyme borreliosis therapy","volume":"122","author":"Bockenstedt","year":"2012","journal-title":"J\u00a0Clin Invest"},{"issue":"27","key":"10.1016\/j.idc.2022.03.006_bib21","doi-asserted-by":"crossref","first-page":"13498","DOI":"10.1073\/pnas.1904170116","article-title":"Borrelia burgdorferi peptidoglycan is a persistent antigen in patients with Lyme arthritis","volume":"116","author":"Jutras","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.idc.2022.03.006_bib22","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1172\/JCI138062","article-title":"Posttreatment Lyme disease syndromes: distinct pathogenesis caused by maladaptive host responses","volume":"130","author":"Steere","year":"2020","journal-title":"J\u00a0Clin Invest"},{"issue":"5","key":"10.1016\/j.idc.2022.03.006_bib23","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/art.34383","article-title":"Association of a toll-like receptor 1 polymorphism with heightened Th1 inflammatory responses and antibiotic-refractory Lyme arthritis","volume":"64","author":"Strle","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"S3","key":"10.1016\/j.idc.2022.03.006_bib24","doi-asserted-by":"crossref","first-page":"S259","DOI":"10.1093\/cid\/ciq117","article-title":"Relationship between immunity to Borrelia burgdorferi outer-surface protein A (OspA) and Lyme arthritis","volume":"52","author":"Steere","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.idc.2022.03.006_bib25","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1002\/art.27468","article-title":"Treg cell numbers and function in patients with antibiotic-refractory or antibiotic-responsive Lyme arthritis","volume":"62","author":"Shen","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.idc.2022.03.006_bib26","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1002\/art.37910","article-title":"Dysregulation of CD4+CD25(high) T\u00a0cells in the synovial fluid of patients with antibiotic-refractory Lyme arthritis","volume":"65","author":"Vudattu","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.idc.2022.03.006_bib27","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/art.37732","article-title":"A\u00a0novel human autoantigen, endothelial cell growth factor, is a target of T and B cell responses in patients with Lyme disease","volume":"65","author":"Drouin","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.idc.2022.03.006_bib28","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1002\/art.38618","article-title":"Antibodies to endothelial cell growth factor and obliterative microvascular lesions in the synovium of patients with antibiotic-refractory Lyme arthritis","volume":"66","author":"Londo\u00f1o","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.idc.2022.03.006_bib29","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jaut.2016.02.005","article-title":"Matrix metalloproteinase-10 is a target of T and B cell responses that correlate with synovial pathology in patients with antibiotic-refractory Lyme arthritis","volume":"69","author":"Crowley","year":"2016","journal-title":"J\u00a0Autoimmun"},{"issue":"11","key":"10.1016\/j.idc.2022.03.006_bib30","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1002\/art.40566","article-title":"Correlation of Lyme disease-associated IgG4 autoantibodies with synovial pathology in antibiotic-refractory Lyme arthritis","volume":"70","author":"Sulka","year":"2018","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"10.1016\/j.idc.2022.03.006_bib31","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s11832-014-0602-3","article-title":"Lyme arthritis of the pediatric lower extremity in the setting of polyarticular disease","volume":"8","author":"Aiyer","year":"2014","journal-title":"J\u00a0Child Orthop"},{"issue":"12","key":"10.1016\/j.idc.2022.03.006_bib32","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1002\/acr.22086","article-title":"Lyme arthritis: a comparison of presentation, synovial fluid analysis, and treatment course in children and adults","volume":"65","author":"Daikh","year":"2013","journal-title":"Arthritis Care Res"},{"issue":"8","key":"10.1016\/j.idc.2022.03.006_bib33","first-page":"2124","article-title":"Distinguishing Lyme from septic knee monoarthritis in Lyme disease-endemic areas","volume":"66","author":"Deanehan","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"10.1016\/j.idc.2022.03.006_bib34","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.idc.2015.02.012","article-title":"Posttreatment Lyme disease syndrome","volume":"29","author":"Aucott","year":"2015","journal-title":"Infect Dis Clin North Am"},{"issue":"1","key":"10.1016\/j.idc.2022.03.006_bib35","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/art.39866","article-title":"Autoimmune arthritides, rheumatoid arthritis, psoriatic arthritis, or peripheral spondyloarthritis following lyme disease","volume":"69","author":"Arvikar","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"10.1016\/j.idc.2022.03.006_bib36","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1086\/322669","article-title":"Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10-20 years after active Lyme disease","volume":"33","author":"Kalish","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"31","key":"10.1016\/j.idc.2022.03.006_bib37","first-page":"590","article-title":"Recommendations for test performance and interpretation from the second international conference on serologic diagnosis of lyme disease","volume":"44","year":"1995","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"32","key":"10.1016\/j.idc.2022.03.006_bib38","doi-asserted-by":"crossref","first-page":"703","DOI":"10.15585\/mmwr.mm6832a4","article-title":"Updated CDC recommendation for serologic diagnosis of lyme disease","volume":"68","author":"Mead","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.idc.2022.03.006_bib39","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1086\/589242","article-title":"Prospective study of serologic tests for Lyme disease","volume":"47","author":"Steere","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2022.03.006_bib40","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1128\/IAI.00048-08","article-title":"A\u00a0genome-wide proteome array reveals a limited set of immunogens in natural infections of humans and white-footed mice with Borrelia Burgdorferi","volume":"76","author":"Barbour","year":"2008","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.idc.2022.03.006_bib41","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1128\/CVI.00383-12","article-title":"Misdiagnosis of late-onset Lyme arthritis by inappropriate use of Borrelia burgdorferi immunoblot testing with synovial fluid","volume":"19","author":"Barclay","year":"2012","journal-title":"Clin Vaccin Immunol"},{"issue":"6","key":"10.1016\/j.idc.2022.03.006_bib42","doi-asserted-by":"crossref","first-page":"798","DOI":"10.7326\/0003-4819-104-6-798","article-title":"Borrelia burgdorferi in joint fluid in chronic Lyme arthritis","volume":"104","author":"Snydman","year":"1986","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.idc.2022.03.006_bib43","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM199401273300401","article-title":"Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid in Lyme arthritis","volume":"330","author":"Nocton","year":"1994","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.idc.2022.03.006_bib44","doi-asserted-by":"crossref","first-page":"e881","DOI":"10.1097\/PEC.0000000000002455","article-title":"Validation of septic knee monoarthritis prediction rule in a lyme disease endemic area","volume":"38","author":"Grant","year":"2022","journal-title":"Pediatr Emerg Care"},{"issue":"1","key":"10.1016\/j.idc.2022.03.006_bib45","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1148\/radiology.154.1.3964949","article-title":"Lyme arthritis: radiologic findings","volume":"154","author":"Lawson","year":"1985","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.idc.2022.03.006_bib46","doi-asserted-by":"crossref","first-page":"e605","DOI":"10.1097\/RHU.0000000000001732","article-title":"The value of musculoskeletal ultrasound for evaluation of postinfectious lyme arthritis","volume":"28","author":"Miller","year":"2022","journal-title":"J\u00a0Clin Rheumatol"},{"issue":"14","key":"10.1016\/j.idc.2022.03.006_bib47","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1056\/NEJM198504043121401","article-title":"Successful parenteral penicillin therapy of established Lyme arthritis","volume":"312","author":"Steere","year":"1985","journal-title":"N\u00a0Engl J Med"},{"issue":"1896","key":"10.1016\/j.idc.2022.03.006_bib48","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(88)92011-9","article-title":"Treatment of late Lyme borreliosis--randomised comparison of ceftriaxone and penicillin","volume":"1","author":"Dattwyler","year":"1988","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.idc.2022.03.006_bib49","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/art.1780370616","article-title":"Treatment of lyme arthritis","volume":"37","author":"Steere","year":"1994","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.idc.2022.03.006_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cid\/ciaa1215","article-title":"Clinical practice guidelines by the infectious diseases society of America (IDSA), American Academy of neurology (AAN), and American college of rheumatology (ACR): 2020 guidelines for the prevention, diagnosis and treatment of lyme disease","volume":"72","author":"Lantos","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2022.03.006_bib51","doi-asserted-by":"crossref","first-page":"273","DOI":"10.7326\/0003-4819-117-4-273","article-title":"Comparison of cefuroxime axetil and doxycycline in the treatment of early Lyme disease","volume":"117","author":"Nadelman","year":"1992","journal-title":"Ann Intern Med"},{"issue":"11\u201312","key":"10.1016\/j.idc.2022.03.006_bib52","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00508-005-0361-8","article-title":"A\u00a0comparison of two treatment regimens of ceftriaxone in late Lyme disease","volume":"117","author":"Dattwyler","year":"2005","journal-title":"Wien Klin Wochenschr"},{"issue":"13","key":"10.1016\/j.idc.2022.03.006_bib53","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1212\/01.WNL.0000284604.61160.2d","article-title":"A\u00a0randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy","volume":"70","author":"Fallon","year":"2008","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.idc.2022.03.006_bib54","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s10096-007-0340-2","article-title":"Duration of antibiotic treatment in disseminated Lyme borreliosis: a double-blind, randomized, placebo-controlled, multicenter clinical study","volume":"26","author":"Oksi","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2022.03.006_bib55","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/ana.410380417","article-title":"Neuroborreliosis in the nonhuman primate: Borrelia burgdorferi persists in the central nervous system","volume":"38","author":"Pachner","year":"1995","journal-title":"Ann Neurol"},{"issue":"7","key":"10.1016\/j.idc.2022.03.006_bib56","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s00296-013-2923-9","article-title":"Intraarticular corticosteroids in refractory childhood Lyme arthritis","volume":"34","author":"Nimmrich","year":"2014","journal-title":"Rheumatol Int"},{"issue":"8","key":"10.1016\/j.idc.2022.03.006_bib57","doi-asserted-by":"crossref","first-page":"952","DOI":"10.3899\/jrheum.180829","article-title":"Intraarticular glucocorticoid injection as second-line treatment for lyme arthritis in children","volume":"46","author":"Horton","year":"2019","journal-title":"J\u00a0Rheumatol"},{"issue":"8","key":"10.1016\/j.idc.2022.03.006_bib58","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/art.1780340817","article-title":"Treatment of refractory chronic Lyme arthritis with arthroscopic synovectomy","volume":"34","author":"Schoen","year":"1991","journal-title":"Arthritis Rheum"}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552022000368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552022000368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:29:25Z","timestamp":1760196565000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891552022000368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0891552022000368"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2022.03.006","relation":{},"ISSN":["0891-5520"],"issn-type":[{"value":"0891-5520","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lyme Arthritis","name":"articletitle","label":"Article Title"},{"value":"Infectious Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idc.2022.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}